Apyx Total Assets from 2010 to 2024

APYX Stock

USD 1.61 0.08 4.73%

Apyx Medical Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1995-12-31

Previous Quarter

65.4 M

Current Value

60.7 M

Quarterly Volatility

25.4 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 736.2 K, Interest Expense of 2.6 M or Selling General Administrative of 51.3 M, as well as many indicators such as Price To Sales Ratio of 1.65, Dividend Yield of 0.0 or PTB Ratio of 3.23. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.

Check out the analysis of Apyx Medical Correlation against competitors.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Total Assets Growth Pattern

Below is the plot of the Total Assets of Apyx Medical over the last few years. Total assets refers to the total amount of Apyx Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Apyx Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Apyx Medical's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 79.24 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Apyx Total Assets Regression Statistics

	Arithmetic Mean	50,194,233
	Geometric Mean	40,152,689
	Coefficient Of Variation	56.15
	Mean Deviation	24,796,716
	Median	35,110,000
	Standard Deviation	28,183,849
	Sample Variance	794.3T
	Range	92M
	R-Value	0.82
	Mean Square Error	287.2T
	R-Squared	0.66
	Significance	0.0002
	Slope	5,136,216
	Total Sum of Squares	11120.6T

Apyx Total Assets History

	2024	83.2 M
	2023	79.2 M
	2022	51.8 M
	2021	68.7 M
	2020	74.1 M
	2019	84.7 M
	2018	95.6 M

Other Fundumenentals of Apyx Medical

Intangibles To Total Assets

Apyx Medical Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.19	-0.6	0.15	0.67	0.66	-0.45	0.5	1.0	0.71	-0.72	-0.05	0.32	0.66	0.88	-0.58	0.71	-0.69	-0.89	0.92	0.96	0.43
Total Stockholder Equity	0.81		0.43	-0.77	0.63	0.29	0.45	-0.31	-0.1	0.82	0.54	-0.56	0.06	0.23	0.29	0.95	-0.56	0.5	-0.58	-0.74	0.89	0.82	-0.12
Current Deferred Revenue	0.19	0.43		-0.51	0.35	0.03	0.0	-0.26	-0.31	0.21	-0.02	0.02	-0.03	0.17	-0.12	0.27	0.08	0.15	-0.06	-0.07	0.26	0.17	-0.46
Net Debt	-0.6	-0.77	-0.51		-0.46	-0.35	-0.48	0.19	0.11	-0.61	-0.46	0.51	-0.16	-0.17	-0.48	-0.72	0.4	-0.44	0.46	0.61	-0.67	-0.6	0.2
Retained Earnings	0.15	0.63	0.35	-0.46		-0.49	-0.27	0.08	-0.68	0.16	-0.04	-0.01	0.09	-0.12	-0.4	0.51	-0.1	-0.3	-0.03	-0.07	0.42	0.29	-0.67
Accounts Payable	0.67	0.29	0.03	-0.35	-0.49		0.82	-0.35	0.71	0.67	0.6	-0.67	0.04	0.24	0.87	0.41	-0.42	0.82	-0.59	-0.74	0.46	0.55	0.62
Net Receivables	0.66	0.45	0.0	-0.48	-0.27	0.82		-0.3	0.45	0.66	0.74	-0.73	0.11	0.27	0.87	0.53	-0.57	0.83	-0.66	-0.82	0.51	0.56	0.4
Good Will	-0.45	-0.31	-0.26	0.19	0.08	-0.35	-0.3		-0.28	-0.38	-0.18	-0.14	0.78	-0.72	-0.3	-0.17	0.05	-0.18	0.12	0.16	-0.15	-0.22	-0.06
Total Liab	0.5	-0.1	-0.31	0.11	-0.68	0.71	0.45	-0.28		0.48	0.41	-0.39	-0.18	0.21	0.69	0.1	-0.14	0.49	-0.33	-0.41	0.25	0.41	0.92
Total Current Assets	1.0	0.82	0.21	-0.61	0.16	0.67	0.66	-0.38	0.48		0.71	-0.77	0.03	0.24	0.65	0.9	-0.6	0.72	-0.71	-0.9	0.94	0.97	0.42
Short Term Debt	0.71	0.54	-0.02	-0.46	-0.04	0.6	0.74	-0.18	0.41	0.71		-0.63	0.05	0.33	0.68	0.62	-0.56	0.71	-0.65	-0.81	0.67	0.69	0.46
Intangible Assets	-0.72	-0.56	0.02	0.51	-0.01	-0.67	-0.73	-0.14	-0.39	-0.77	-0.63		-0.58	0.27	-0.68	-0.76	0.63	-0.71	0.71	0.88	-0.77	-0.8	-0.4
Common Stock	-0.05	0.06	-0.03	-0.16	0.09	0.04	0.11	0.78	-0.18	0.03	0.05	-0.58		-0.82	-0.02	0.24	-0.38	0.19	-0.19	-0.2	0.18	0.15	-0.04
Property Plant Equipment	0.32	0.23	0.17	-0.17	-0.12	0.24	0.27	-0.72	0.21	0.24	0.33	0.27	-0.82		0.3	0.06	0.06	0.32	-0.17	-0.2	0.11	0.1	0.18
Long Term Debt	0.66	0.29	-0.12	-0.48	-0.4	0.87	0.87	-0.3	0.69	0.65	0.68	-0.68	-0.02	0.3		0.41	-0.33	0.72	-0.61	-0.77	0.47	0.56	0.58
Net Tangible Assets	0.88	0.95	0.27	-0.72	0.51	0.41	0.53	-0.17	0.1	0.9	0.62	-0.76	0.24	0.06	0.41		-0.67	0.58	-0.66	-0.84	0.97	0.94	0.1
Long Term Debt Total	-0.58	-0.56	0.08	0.4	-0.1	-0.42	-0.57	0.05	-0.14	-0.6	-0.56	0.63	-0.38	0.06	-0.33	-0.67		-0.61	0.5	0.62	-0.54	-0.57	-0.28
Capital Surpluse	0.71	0.5	0.15	-0.44	-0.3	0.82	0.83	-0.18	0.49	0.72	0.71	-0.71	0.19	0.32	0.72	0.58	-0.61		-0.69	-0.84	0.6	0.62	0.56
Deferred Long Term Liab	-0.69	-0.58	-0.06	0.46	-0.03	-0.59	-0.66	0.12	-0.33	-0.71	-0.65	0.71	-0.19	-0.17	-0.61	-0.66	0.5	-0.69		0.81	-0.7	-0.71	-0.35
Short Long Term Debt	-0.89	-0.74	-0.07	0.61	-0.07	-0.74	-0.82	0.16	-0.41	-0.9	-0.81	0.88	-0.2	-0.2	-0.77	-0.84	0.62	-0.84	0.81		-0.87	-0.88	-0.43
Net Invested Capital	0.92	0.89	0.26	-0.67	0.42	0.46	0.51	-0.15	0.25	0.94	0.67	-0.77	0.18	0.11	0.47	0.97	-0.54	0.6	-0.7	-0.87		0.98	0.24
Net Working Capital	0.96	0.82	0.17	-0.6	0.29	0.55	0.56	-0.22	0.41	0.97	0.69	-0.8	0.15	0.1	0.56	0.94	-0.57	0.62	-0.71	-0.88	0.98		0.37
Capital Stock	0.43	-0.12	-0.46	0.2	-0.67	0.62	0.4	-0.06	0.92	0.42	0.46	-0.4	-0.04	0.18	0.58	0.1	-0.28	0.56	-0.35	-0.43	0.24	0.37

Click cells to compare fundamentals

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	79.2 M	83.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC